Testosterone has become the mythological hormone of masculinity — the chemical explanation for everything from ambition to aggression to libido, and the supposed solution for everything from fatigue to depression to declining vigor. The reality, as revealed by actual endocrinology research, is considerably more interesting and considerably less simple than either the marketing or the mythology suggests.
What testosterone actually does in the male body is not fully understood even by endocrinologists. What research shows about what raises and lowers it is often at odds with popular belief. And the testosterone replacement therapy industry — now a multi-billion dollar global enterprise — has outrun the evidence for many of its applications in ways that have real consequences for real men.
What Testosterone Actually Does
Testosterone is an anabolic steroid — a steroid in the technical sense of being derived from cholesterol, anabolic in the sense of being involved in building tissue. It is produced primarily in the Leydig cells of the testes (roughly 95 percent of male testosterone production) and in small amounts by the adrenal glands.
In the male body, testosterone serves several distinct functions. During fetal development, it drives the differentiation of male reproductive anatomy. At puberty, it drives the development of secondary sexual characteristics: muscle mass increase, bone density increase, deepened voice, body and facial hair, and the growth and maturation of the testes and penis. In adult men, it maintains muscle mass and bone density, supports red blood cell production, regulates libido, and plays a role in mood and cognitive function.
The cognitive and mood roles are genuinely complex and widely misunderstood. Testosterone is often cited as a driver of aggression, but the research on this relationship is considerably more nuanced than the popular version. The clearest finding is that testosterone amplifies responses to social challenges — men with higher testosterone show stronger reactions (in either direction) to threat and opportunity. This can manifest as aggression in competitive or threatening contexts, but the same hormonal state shows up as confidence, assertiveness, and prosocial dominance-seeking in cooperative or rewarding contexts.
A 2012 review by Justin Carré and Cheryl McCormick in Hormones and Behavior synthesized the experimental literature and concluded that testosterone’s relationship to aggression is mediated by social context, provocation, and individual difference — and that the simple “more testosterone = more aggressive” model is not supported by the data. Men who are provoked show testosterone-aggression correlations; men in cooperative settings often show the reverse.
What Affects Testosterone Levels
The practical question for most men is what controllable factors influence their testosterone levels. The evidence is uneven in quality, but several factors show consistent and replicable effects.
Sleep Is the Single Most Important Factor
The most robust finding in the lifestyle-testosterone research is also the most boring: sleep. A landmark study published in JAMA in 2011 (Leproult and Van Cauter) had young healthy men sleep for 5 hours per night for one week and measured the resulting testosterone change: an average decrease of 10-15 percent, equivalent to the testosterone decline associated with 10-15 years of aging. This is a dramatic effect produced by a one-week intervention. The reversal is equally dramatic — men who resume adequate sleep rapidly restore testosterone levels.
The mechanism is clear: testosterone production follows a circadian rhythm, with peak production occurring during sleep, particularly during REM sleep. Interrupt the sleep, interrupt the production. The clinical implications are significant: many men who present with low testosterone symptoms are sleep-deprived, and testosterone replacement therapy prescribed to such men is treating the symptom (low testosterone) rather than the cause (inadequate sleep).
Body Fat: The Aromatase Problem
The relationship between body fat and testosterone is bidirectional and clinically important. Low testosterone promotes fat gain, particularly visceral fat. Visceral fat contains high concentrations of the enzyme aromatase, which converts testosterone to estradiol. More visceral fat means more aromatase activity, which means more testosterone converted to estrogen, which means lower testosterone — which means more fat gain. This is a feedback loop.
The practical implication: men with significant obesity-related fat gain frequently have low testosterone that will respond to fat loss rather than hormone replacement. Multiple studies have shown that weight loss of 10-15 percent in obese men produces testosterone increases comparable to low-dose TRT, without the side effects. This is rarely the first intervention offered by direct-to-consumer testosterone clinics, which have a financial interest in prescription therapy.
Exercise: What the Evidence Shows
High-intensity exercise, including resistance training, produces short-term testosterone spikes — the elevation is measurable for hours after a workout and is well-documented in the research literature. Whether this produces sustained long-term changes in baseline testosterone is less clear. Several long-term studies have found no significant difference in resting testosterone between men who exercise regularly and sedentary men, suggesting that the exercise effect is primarily acute rather than tonic.
Overtraining is a real phenomenon with real hormonal consequences. Elite endurance athletes often show chronically suppressed testosterone, a state called “exercise-induced hypogonadism” that is associated with high training volume without adequate recovery. The men most aggressively pursuing testosterone optimization through intensive training may be inadvertently suppressing the hormone they are trying to raise.
Stress and Cortisol
Cortisol and testosterone have an inverse relationship: chronic stress elevates cortisol, and chronically elevated cortisol suppresses testosterone production at the hypothalamic-pituitary-testicular axis level. This is one of the most important and least-discussed aspects of the testosterone conversation, because chronic stress is endemic in the demographic most concerned about testosterone levels.
The suppression mechanism is direct: cortisol inhibits gonadotropin-releasing hormone (GnRH) from the hypothalamus, reducing the downstream luteinizing hormone (LH) signal to the testes, reducing testosterone production. Chronic stress literally tells your body that this is not a good time to be reproducing, and the hormonal system responds accordingly.
Effective stress management — which the research shows involves adequate sleep, social connection, exercise, and some form of contemplative or psychological practice — produces measurable testosterone benefits via the cortisol axis, independently of any direct testosterone effect.
The TRT Industry: What the Evidence Supports
Testosterone replacement therapy is medically indicated and genuinely beneficial for men with hypogonadism — clinically low testosterone (generally defined as below 300 ng/dL) with symptomatic presentation. Symptoms of hypogonadism include sexual dysfunction, reduced libido, fatigue, loss of muscle mass, increased body fat, depressed mood, and cognitive changes. When a man has both the biochemical criterion and the clinical symptoms, TRT is well-supported by evidence.
The problem is scope. The direct-to-consumer TRT industry has expanded the indication far beyond this. Men with testosterone in the low-normal or normal range — 400-600 ng/dL — are being prescribed TRT based on symptoms alone, or based on their testosterone being below the population average, rather than below the clinical threshold. This is, by the standards of evidence-based medicine, aggressive over-prescription.
The risks of TRT in men who do not have true hypogonadism are real. Exogenous testosterone suppresses the hypothalamic-pituitary-testicular axis, reducing or eliminating endogenous testosterone production — and sometimes causing it to not recover adequately after TRT is discontinued, particularly in younger men. Fertility is significantly impaired during TRT (it is effectively contraceptive) and may not fully recover. Cardiovascular risk has been the subject of significant controversy: a 2023 trial (TRAVERSE) found no significant increase in major cardiovascular events in men with symptomatic hypogonadism and cardiovascular risk factors on TRT, which was reassuring — but this does not necessarily generalize to men without clinical hypogonadism.
There is also the dependency issue. Many men who begin TRT find that their endogenous production does not recover when they stop, meaning they have traded their natural hormonal axis for pharmaceutical dependency. For men with true hypogonadism, this trade is worth it. For men with normal testosterone who want more, it is a significant commitment being entered without adequate informed consent.
Supplements: What Works and What Doesn’t
The testosterone supplement market makes extraordinary claims on minimal evidence. A realistic assessment of what the research shows:
Vitamin D: Men who are vitamin D deficient (a large proportion of men in northern latitudes and men who work primarily indoors) show lower testosterone that partially responds to vitamin D supplementation. This is not a testosterone booster for men who are replete — it is a correction for deficiency. The effect size in repleted men is small. Supplementation is warranted for men who are deficient regardless of testosterone concerns; it is not a meaningful testosterone intervention for men who are sufficient.
Zinc: Similar story. Zinc deficiency impairs testosterone production; zinc supplementation in deficient men shows testosterone benefits. In zinc-sufficient men, supplementation does not raise testosterone. The majority of supplement products marketed as “testosterone boosters” contain zinc on this basis, while failing to disclose that the benefit is specific to deficiency.
Ashwagandha: The most credible adaptogen in the testosterone research. Several randomized controlled trials — though of modest size and quality — have shown that ashwagandha supplementation is associated with significant cortisol reduction and modest testosterone increases, plausibly via the cortisol-suppression mechanism described above. This is not a dramatic effect, but it is probably real and the mechanism is coherent.
Everything else: D-aspartic acid, tribulus terrestris, fenugreek, DHEA — the evidence for these in men with normal testosterone function is weak and inconsistent. Several have been tested in good-quality trials and shown no significant effect. They remain in products because they are inexpensive, legal, and marketable.
The Conversation Every Man Should Have with His Doctor
If you’re concerned about testosterone, the most useful thing you can do is get tested — specifically, a morning serum total testosterone and free testosterone test (testosterone is highest in the morning due to the circadian production pattern; afternoon testing systematically underestimates levels). If results are below 300 ng/dL with consistent symptoms, you have a legitimate clinical conversation to have about intervention, which may include TRT but should start with lifestyle factors.
If results are in the 300-500 ng/dL range with symptoms, the conversation is more complex. Many symptoms attributed to “low testosterone” in this range — fatigue, low libido, mood changes — have multiple possible causes. Sleep quality, thyroid function, depression, and chronic stress all produce similar symptom profiles and are worth evaluating before attributing symptoms to testosterone alone.
If results are above 500 ng/dL, you almost certainly do not have a testosterone problem, and any symptoms you’re experiencing require investigation elsewhere.
Related Reading: